Analyst Ratings for Akcea Therapeutics, Inc. (AKCA) [Neutrals]

AKCA Rating Summary

AKCA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AKCA
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $18.15 (-0.1%) * Over Last 12-Mos
Rating Score: 2 / 10   Percentile Rank: 36%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/1/2020 BMO Capital Do Kim Downgrade Market Perform
(Outperform)
18.15
(26.00)
11.38
(18.17)
59.67% Details
8/31/2020 Wells Fargo Jim Birchenough Downgrade Equal Weight
(Overweight)
N/A
(N/A)
11.38
(18.17)
59.67% Details
Like AKCA Ratings? Also take a look at IONS, BLDR, RST, VRTU

AKCA Ratings News